203 related articles for article (PubMed ID: 34680215)
1. The Effect of a Histone Deacetylase Inhibitor (AR-42) and Zoledronic Acid on Adult T-Cell Leukemia/Lymphoma Osteolytic Bone Tumors.
Elshafae SM; Kohart NA; Breitbach JT; Hildreth BE; Rosol TJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680215
[TBL] [Abstract][Full Text] [Related]
2. Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone.
Kohart NA; Elshafae SM; Supsahvad W; Alasonyalilar-Demirer A; Panfil AR; Xiang J; Dirksen WP; Veis DJ; Green PL; Weilbaecher KN; Rosol TJ
J Bone Oncol; 2019 Dec; 19():100257. PubMed ID: 31871882
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.
Kohart NA; Elshafae SM; Demirer AA; Dirksen WP; Breitbach JT; Shu ST; Xiang J; Weilbaecher KN; Rosol TJ
Leuk Lymphoma; 2020 Feb; 61(2):409-419. PubMed ID: 31592701
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1 infected T cells cause bone loss via small extracellular vesicles.
Pokhrel NK; Panfil A; Habib H; Seeniraj S; Joseph A; Rauch D; Cox L; Sprung R; Gilmore PE; Zhang Q; Townsend RR; Yu L; Yilmaz AS; Aurora R; Park W; Ratner L; Weilbaecher KN; Veis DJ
bioRxiv; 2024 Mar; ():. PubMed ID: 38496506
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.
Martin CK; Werbeck JL; Thudi NK; Lanigan LG; Wolfe TD; Toribio RE; Rosol TJ
Cancer Res; 2010 Nov; 70(21):8607-16. PubMed ID: 20959474
[TBL] [Abstract][Full Text] [Related]
6. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
Gao L; Deng H; Zhao H; Hirbe A; Harding J; Ratner L; Weilbaecher K
Blood; 2005 Dec; 106(13):4294-302. PubMed ID: 16118323
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice.
Esser AK; Rauch DA; Xiang J; Harding JC; Kohart NA; Ross MH; Su X; Wu K; Huey D; Xu Y; Vij K; Green PL; Rosol TJ; Niewiesk S; Ratner L; Weilbaecher KN
Oncotarget; 2017 Sep; 8(41):69250-69263. PubMed ID: 29050201
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.
Watanabe T; Yamaguchi K; Takatsuki K; Osame M; Yoshida M
J Exp Med; 1990 Sep; 172(3):759-65. PubMed ID: 2388034
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of bone lesions in multiple myeloma and lymphoma.
Roodman GD
Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma.
Zimmerman B; Sargeant A; Landes K; Fernandez SA; Chen CS; Lairmore MD
Leuk Res; 2011 Nov; 35(11):1491-7. PubMed ID: 21802726
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
Zysk A; DeNichilo MO; Panagopoulos V; Zinonos I; Liapis V; Hay S; Ingman W; Ponomarev V; Atkins G; Findlay D; Zannettino A; Evdokiou A
Cancer Lett; 2017 Feb; 386():141-150. PubMed ID: 27865798
[TBL] [Abstract][Full Text] [Related]
13. A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
Shu ST; Nadella MV; Dirksen WP; Fernandez SA; Thudi NK; Werbeck JL; Lairmore MD; Rosol TJ
Cancer Res; 2007 Dec; 67(24):11859-66. PubMed ID: 18089816
[TBL] [Abstract][Full Text] [Related]
14. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
Luo KW; Ko CH; Yue GG; Gao S; Lee JK; Li G; Fung KP; Leung PC; Evdokiou A; Lau CB
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1025-36. PubMed ID: 25431338
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis.
Duong LT; Wesolowski GA; Leung P; Oballa R; Pickarski M
Mol Cancer Ther; 2014 Dec; 13(12):2898-909. PubMed ID: 25249554
[TBL] [Abstract][Full Text] [Related]
16. Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation.
Bellon M; Ko NL; Lee MJ; Yao Y; Waldmann TA; Trepel JB; Nicot C
Blood; 2013 Jun; 121(25):5045-54. PubMed ID: 23660959
[TBL] [Abstract][Full Text] [Related]
17. Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia.
Okada Y; Tsukada J; Nakano K; Tonai S; Mine S; Tanaka Y
J Bone Miner Res; 2004 Jul; 19(7):1105-11. PubMed ID: 15176993
[TBL] [Abstract][Full Text] [Related]
18. Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.
Yamakawa Y; Tazawa H; Hasei J; Osaki S; Omori T; Sugiu K; Komatsubara T; Uotani K; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Sci; 2017 Sep; 108(9):1870-1880. PubMed ID: 28685948
[TBL] [Abstract][Full Text] [Related]
19. Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report.
Kato H; Koga M; Kobayashi H; Maki H; Ikemura M; Kurokawa M; Nangaku M; Makita N; Ito N
Osteoporos Int; 2021 May; 32(5):1013-1017. PubMed ID: 33128574
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N
J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
